Dr. Evens on Key Highlights from the RWJ Annual Clinical Practice and Research Summit

Partner | Cancer Centers | <b>RWJBarnabas Health and Rutgers Cancer Institute of New Jersey</b>

Andrew M. Evens, DO, MSc, discusses highlights from the 2021 RWJ Annual Clinical and Practice Research Summit.

Andrew M. Evens, DO, MSc, director for clinical services, Rutgers Cancer Institute of New Jersey, system director of Medical Oncology, oncology lead, Combined Medical Group with RWJBarnabas Health, associate vice chancellor, Clinical Innovation and Data Analytics, Rutgers Biomedical and Health Sciences, discusses highlights from the 2021 RWJ Annual Clinical and Practice Research Summit.

The first annual meeting, hosted by RWJ Barnabas Health, covered a host of topics, spanning from hematologic malignancies, multiple myeloma, breast and gynecologic cancers, brain stereotactic radiation therapy, and cellular immunotherapy, Evens says. Moreover, there are multiple disease breakout sessions that were held, in which investigators discussed current trends in particular paradigms, as well as new clinical trials, Evens adds.

Every topic discussed during the summit was anchored in clinical care and the current worldwide standard of care, in the context of current, cutting-edge clinical research being done at RWJBarnabas Health, Evens concludes.